Development of an antisens oligonucleotide therapy for oculopharyngeal muscular dystrophy using iPSC-derived myocytes

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Mathilde Bertheau, Thiéry De Serres‐Bérard, Mathieu Blais, Vincent Picher‐Martel
DOI: 10.5281/zenodo.18631849
Cited by: 0

Fields of Study & Subjects

Muscle Physiology and Disorders Neurogenetic and Muscular Disorders Research Amyotrophic Lateral Sclerosis Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
13 February 2026
Language
EN